{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:04:56Z","timestamp":1761512696209},"reference-count":24,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vaccine.2009.06.026","type":"journal-article","created":{"date-parts":[[2009,6,24]],"date-time":"2009-06-24T14:35:47Z","timestamp":1245854147000},"page":"4876-4878","source":"Crossref","is-referenced-by-count":14,"title":["Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy"],"prefix":"10.1016","volume":"27","author":[{"given":"Samar","family":"Ojaimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim P.","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony M.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.06.026_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000372-200608000-00008","article-title":"Post-injection involutional lipoatrphy: ultrastructural evidence for an activated macrophage phenotype and macrophage related involution of adipocytes","volume":"28","author":"Ahmed","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.vaccine.2009.06.026_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1440-0960.2006.00291.x","article-title":"Leg crossers\u2019 dimple: a form of localised lipoatrophy","volume":"47","author":"Kalouche","year":"2006","journal-title":"Australs J Dermatol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.026_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1525-1470.2000.01759.x","article-title":"Partial lipoatrophy in a Child","volume":"17","author":"Kuperman-Beade","year":"2000","journal-title":"Pediat Dermatol"},{"key":"10.1016\/j.vaccine.2009.06.026_bib4","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1365-4632.2007.03268.x","article-title":"DPT vaccine-induced lipoatrophy: an observational study","volume":"46","author":"Sardana","year":"2007","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.026_bib5","first-page":"S1","article-title":"HPV vaccine and its recommendations","volume":"56","author":"Zimmerman","year":"2007","journal-title":"J Fam Pract"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.026_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0025-6196(11)60898-7","article-title":"Human papillomavirus and vaccination","volume":"83","author":"Huang","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.vaccine.2009.06.026_bib7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2165\/00003495-200666090-00008","article-title":"Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil)","volume":"66","author":"Asif","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2009.06.026_bib8","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1016\/j.vaccine.2008.07.056","article-title":"Prophylactic HPV vaccines: new interventions for cancer control","volume":"26","author":"Barr","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.026_bib9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.06.026_bib10","unstructured":"National Centre for immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) for the Australian Technical Advisory Group on Immunisation (ATAGI). Systematic review of the safety, immunogenecity and efficacy of human papillomavirus vaccines. March; 2007."},{"key":"10.1016\/j.vaccine.2009.06.026_bib11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1097\/01.AOG.0000215986.48590.79","article-title":"Cervical cancer","volume":"107","author":"Moore","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2009.06.026_bib12","series-title":"Gardasil product information","author":"Merck Sharp & Dohme","year":"2008"},{"key":"10.1016\/j.vaccine.2009.06.026_bib13","series-title":"The Australian immunisation handbook","author":"Australian Governement","year":"2008"},{"key":"10.1016\/j.vaccine.2009.06.026_bib14","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.vaccine.2008.08.067","article-title":"Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006\u2013January 2008","volume":"26","author":"Koulova","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.026_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1503\/cmaj.070948","article-title":"Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials","volume":"177","author":"Rambout","year":"2007","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.026_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/520654","article-title":"Quadrivalent human papillomavirus vaccine","volume":"45","author":"Barr","year":"2007","journal-title":"CID"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.026_bib17","first-page":"261","article-title":"Mass psychogenic response to human papillomavirus vaccination","volume":"189","author":"Buttery","year":"2008","journal-title":"MJA"},{"key":"10.1016\/j.vaccine.2009.06.026_bib18","unstructured":"US Food and Drug Administration, Centre for Biologics Evaluation and Research. Information from CDC and FDA on the safety of Gardasil vaccine. [Accessed July 14th 2008] http:\/\/www.fda.gov\/cber\/safety\/gardasil071408.htm."},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.026_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1503\/cmaj.080916","article-title":"Anaphylaxis following quadrivalent human papillomavirus vaccination","volume":"179","author":"Brotherton","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2009.06.026_bib20","doi-asserted-by":"crossref","first-page":"a2642","DOI":"10.1136\/bmj.a2642","article-title":"Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study","volume":"337","author":"Kang","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2009.06.026_bib21","unstructured":"Vaccine Adverse Event Reporting System. [Accessed May 9th 2009] http:\/\/vaers.hhs.gov\/."},{"key":"10.1016\/j.vaccine.2009.06.026_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0190-9622(96)90673-8","article-title":"Localized involutional lipoatrophy: a clinicopathologic study of 16 patients","volume":"35","author":"Dahl","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2009.06.026_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2007.06.030","article-title":"Localized involutional lipoatrophy with epidermal and dermal changes","volume":"58","author":"Abbas","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2009.06.026_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/bmj.38906.704549.7C","article-title":"Effect of needle size on immunogenicity and reactognicity of vaccines in infants: randomised controlled trial","volume":"333","author":"Diggle","year":"2006","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T21:28:39Z","timestamp":1545168519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09008780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":24,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0264410X09008780"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}